Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emodepside phase II trial for treatment of onchocerciasis
PACTR202010898529928Phase 2Not yet recruiting
- Sponsor
- Drugs for Neglected Diseases initiative
- Start
- Mar 2021
- Modality
- Small Molecules, Peptides
- Countries
- 2
01
Overview
Phase 2 trial of emodepside in onchocerciasis, sponsored by Drugs for Neglected Diseases initiative. Planned start Mar 2021; status: not yet recruiting.
02
Drugs
emodepside
03
Conditions
onchocerciasis
Beyond the preview
Go deeper on PACTR202010898529928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202010898529928.